Francisca Kartono Winardi, DO
Dermatology · Northville, MINPI 1508034232
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Galderma Laboratories, L.p. at 32.4% of the total. 2025 is the largest year on record at $49,983, more than ten times the $1,506 reported in 2019. Among dermatology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 805 payments — averaging $77.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$20K
- UCB, Inc.$10K
- Sanofi$8K
- Sun Pharmaceutical Industries Inc.$6K
- Regeneron$5K
- Boehringer Ingelheim$2K
- plus $10K from 37 others
Across 18 payments — averaging $5346.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$56K
- Sanofi US Services Inc.$17K
- Incyte Corporation$14K
- Eli Lilly$9K
What the payments were for
- Consulting fees$25,01040%
- Speaking & faculty fees$18,15029%
- Travel & lodging$2,9845%
- Food & beverage$15,00624%
- Education$9251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$62,075 in reported general payments places this provider in the 90th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $50,417 |
| Fluorouracil | 72 | $5,461 |
| Tacrolimus | 32 | $5,225 |
| Clobetasol Propionate | 92 | $3,307 |
| Metronidazole | 46 | $1,671 |
| Ammonium Lactate | 74 | $1,603 |
| Ketoconazole | 90 | $1,448 |
| Tavaborole | 15 | $1,428 |
| Tretinoin | 22 | $1,210 |
| CiclopiroxCiclopirox Olamine | 52 | $1,082 |
| Fluocinonide | 33 | $1,041 |
| Clindamycin Phosphate | 31 | $1,013 |
| Betamethasone Dipropionate | 21 | $979 |
| ValacyclovirValacyclovir Hcl | 29 | $714 |
| Desonide | 21 | $643 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Northville
- Linda Stein GoldWest Bloomfield$3.3M
- Kristi HawleyCaledonia$2.2M
- David AltmanWarren$1.9M
- Michael SiegelWaterford$708K
- Johann GudjonssonAnn Arbor$535K
- Michael DormanWest Bloomfield$433K
- Steven DaveluyDearborn$350K
- Benjamin WorkmanMidland$284K
- Diana WestgateKalamazoo$252K
- Christofer BuattiAuburn Hills$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.